S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 21.85 SEK 0.23% Market Closed
Market Cap: kr1.2B

Cash Flow Statement

Cash Flow Statement
SynAct Pharma AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(77)
(85)
(96)
(101)
(106)
(142)
(159)
(164)
(224)
(192)
(168)
(160)
(90)
(92)
(104)
(115)
Depreciation & Amortization
0
0
0
0
1
0
0
0
75
0
0
0
1
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
8
0
0
0
10
0
0
0
Other Non-Cash Items
0
0
1
1
(0)
1
7
10
10
95
92
90
10
3
(0)
(1)
Cash Taxes Paid
(5)
(5)
(5)
(5)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
(0)
0
0
1
1
1
2
2
2
Change in Working Capital
12
13
3
(15)
(13)
9
23
52
39
16
(7)
(21)
(10)
(17)
15
24
Cash from Operating Activities
(65)
N/A
(72)
-10%
(92)
-29%
(116)
-25%
(118)
-2%
(131)
-11%
(129)
+2%
(102)
+21%
(100)
+2%
(81)
+19%
(82)
-2%
(92)
-11%
(89)
+3%
(107)
-20%
(89)
+16%
(91)
-2%
Investing Cash Flow
Other Items
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(0)
N/A
0
N/A
0
N/A
0
N/A
0
+1 250%
0
+874%
0
+50%
0
+1%
0
-7%
0
-64%
0
-99%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
80
0
0
0
229
0
0
0
59
0
0
0
94
0
0
0
Net Issuance of Debt
(0)
0
0
0
(1)
0
0
0
(1)
0
0
0
(1)
0
0
0
Other
(6)
(0)
125
125
(27)
201
75
75
(5)
54
102
102
(6)
107
96
131
Cash from Financing Activities
74
N/A
(0)
N/A
125
N/A
125
0%
201
+61%
201
0%
75
-62%
75
+0%
54
-28%
54
+0%
102
+88%
102
+0%
87
-14%
107
+23%
96
-11%
131
+37%
Change in Cash
Effect of Foreign Exchange Rates
0
(0)
2
1
1
1
1
0
(0)
0
(1)
(0)
1
(1)
(0)
(0)
Net Change in Cash
9
N/A
(72)
N/A
34
N/A
10
-69%
84
+703%
71
-15%
(52)
N/A
(26)
+50%
(46)
-76%
(27)
+42%
18
N/A
10
-48%
(1)
N/A
(0)
+67%
6
N/A
39
+548%
Free Cash Flow
Free Cash Flow
(65)
N/A
(72)
-10%
(92)
-29%
(116)
-25%
(118)
-2%
(131)
-11%
(129)
+2%
(102)
+21%
(100)
+2%
(81)
+19%
(82)
-2%
(92)
-11%
(89)
+3%
(107)
-20%
(89)
+16%
(91)
-2%